Vitamin A and Breast Cancer Survival: A Systematic Review and Meta-analysis

被引:42
|
作者
He, Juanjuan [1 ]
Gu, Yuanting [1 ]
Zhang, Shaojin [2 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Breast Surg, Zhengzhou, Henan, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 1, Dept Urol Surg, 1 Jianshe Dong Rd, Zhengzhou 450052, Henan, Peoples R China
关键词
alpha-Carotene; beta-Carotene; Meta-regression; Overall survival; TREND ESTIMATION; DIETARY FACTORS; PREMORBID DIET; SUPPLEMENT USE; RETINOIC ACID; RISK; GROWTH; WOMEN; PROGNOSIS; ASSOCIATION;
D O I
10.1016/j.clbc.2018.07.025
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We conducted a systemic review and meta-analysis to summarize the association between dietary or supplement vitamin A and breast cancer survival. The dietary intake of beta-carotene was significantly associated statistically with improved breast cancer overall survival. We found no effects from the intake of other vitamin A derivatives (eg, alpha-carotene, beta-cryptoxanthin, lycopene, retinol, lutein) on breast cancer prognosis. Background: The association between vitamin A intake and breast cancer survival has been inconsistent. We conducted a systemic review and meta-analysis to summarize the results on the association between dietary or supplement vitamin A and its derivatives and breast cancer-specific survival and overall survival (OS). Materials and Methods: A comprehensive search of PubMed and EMBASE was performed from inception to January 31, 2018. The summary hazard ratios and 95% confidence intervals were estimated using a random effects model. Results: Ten studies (8 cohort, 1 clinical trial, and 1 of pooled studies), with 19,450 breast cancer cases, were included in the meta-analysis. The dietary intake of beta-carotene was significantly associated with improved breast cancer OS, with a summary hazard ratio of 0.70 (95% confidence interval, 0.50-0.99; I-2 = 37.5%) for the highest versus lowest intake and 0.93 (95% confidence interval, 0.88-0.99; I-2 = 38.7%) per 1200 mu g/day increment of intake when assessing diet before diagnosis. Meta-regression analysis showed that adjustment for body mass index was a modified factor for the association between the intake of beta-carotene and breast cancer OS (P = .013). However, the intake of other vitamin A derivatives (eg, alpha-carotene, beta-cryptoxanthin, lycopene, retinol, lutein) had no effect on breast cancer prognosis when assessing diet before and after the diagnosis. Conclusion: Our findings suggest limited evidence for the significantly inverse association between the prediagnosis dietary intake of beta-carotene and OS among women with breast cancer. However, the intake of other vitamin A derivatives was not significantly associated with survival. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:E1389 / E1400
页数:12
相关论文
共 50 条
  • [21] Soy and isoflavones consumption and breast cancer survival and recurrence: a systematic review and meta-analysis
    Qiu, Shumin
    Jiang, Chongmin
    EUROPEAN JOURNAL OF NUTRITION, 2019, 58 (08) : 3079 - 3090
  • [22] Soy and isoflavones consumption and breast cancer survival and recurrence: a systematic review and meta-analysis
    Shumin Qiu
    Chongmin Jiang
    European Journal of Nutrition, 2019, 58 : 3079 - 3090
  • [23] Pilates for breast cancer: A systematic review and meta-analysis
    Espindula, Roberta Costa
    Nadas, Gabriella Barbosa
    da Rosa, Maria Ines
    Foster, Charlie
    de Araujo, Florentino Cardoso
    Grande, Antonio Jose
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2017, 63 (11): : 1006 - 1011
  • [24] The Global and Regional Survival Rate of Women With Breast Cancer: A Systematic Review and Meta-analysis
    Maajani, Khadije
    Jalali, Arash
    Alipour, Sadaf
    Khodadost, Mahmoud
    Tohidinik, Hamid Reza
    Yazdani, Kamran
    CLINICAL BREAST CANCER, 2019, 19 (03) : 165 - 177
  • [25] Artificial intelligence in breast cancer survival prediction: a comprehensive systematic review and meta-analysis
    Javanmard, Zohreh
    Shahraki, Saba Zarean
    Safari, Kosar
    Omidi, Abbas
    Raoufi, Sadaf
    Rajabi, Mahsa
    Akbari, Mohammad Esmaeil
    Aria, Mehrad
    FRONTIERS IN ONCOLOGY, 2025, 14
  • [26] Time since last pregnancy and breast cancer survival: A systematic review and meta-analysis
    Valachis, A.
    Nearchou, A. D.
    Mauri, D.
    Lind, P. A.
    Polyzos, N. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [27] The Impact of lncRNA Dysregulation on Clinicopathology and Survival of Breast Cancer: A Systematic Review and Meta-analysis
    Tian, Tian
    Wang, Meng
    Lin, Shuai
    Guo, Yan
    Dai, Zhiming
    Liu, Kang
    Yang, Pengtao
    Dai, Cong
    Zhu, Yuyao
    Zheng, Yi
    Xu, Peng
    Zhu, Wenge
    Dai, Zhijun
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2018, 12 : 359 - 369
  • [28] The effect of BMI on survival outcome of breast cancer patients: a systematic review and meta-analysis
    Kong, Yu-huan
    Huang, Jing-yi
    Ding, Ye
    Chen, Shu-hua
    Li, Qiu-shuang
    Xiong, Yang
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025, 27 (02): : 403 - 416
  • [29] Change in Survival in Metastatic Breast Cancer with Treatment Advances: Meta-Analysis and Systematic Review
    Caswell-Jin, Jennifer L.
    Plevritis, Sylvia K.
    Tian, Lu
    Cadham, Christopher J.
    Xu, Cong
    Stout, Natasha K.
    Sledge, George W.
    Mandelblatt, Jeanne S.
    Kurian, Allison W.
    JNCI CANCER SPECTRUM, 2018, 2 (04)
  • [30] Efficacy of vitamin D supplementation in overall survival of cancer patients: Systematic review and meta-analysis
    Irawan, V. R.
    Haroen, H.
    Pandelaki, K.
    Rotty, L. W. A.
    Lasut, P. F. C.
    Hendratta, C.
    Wariki, W. M. V.
    ANNALS OF ONCOLOGY, 2023, 34 : S1636 - S1636